Zhang, Y., Zhang, L., Zhang, Y., Fan, X., Yang, W., Yu, B., . . . Li, F. (2019). YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways. Front Pharmacol.
Stile di citazione ChicagoZhang, Yu, Ling Zhang, Yan Zhang, Xiaoxue Fan, Weiwei Yang, Boyang Yu, Junping Kou, e Fang Li. "YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function Via Regulating ROS Generation and CaMKII Signaling Pathways." Front Pharmacol 2019.
Citazione MLAZhang, Yu, et al. "YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function Via Regulating ROS Generation and CaMKII Signaling Pathways." Front Pharmacol 2019.